Results 11 to 20 of about 12,136 (324)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report- [PDF]

Korean Journal of Anesthesiology, 2020
Background In sugammadex-induced anaphylaxis, sugammadex and/or sugammadex-rocuronium complex have possible allergenic epitope. Case We report a case of sugammadex-induced anaphylaxis during general anesthesia in a 60-year-old male undergoing orthopedic ...
Shu Chung Choi, Sangbin Han, Jueun Kwak, Ji Yung Lee   +3 more
doaj   +5 more sources

Sugammadex [PDF]

Journal of PeriAnesthesia Nursing, 2016
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing
Cada, Dennis J, Levien, Terri L, Baker, Danial E   +2 more
  +9 more sources

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats [PDF]

Revista Brasileira de Anestesiologia, 2021
Background and objectives: Sugammadex is an alternative pharmacological drug capable of reversing neuromuscular blockades without the limitations that are presented by anticholinesterase drugs.
Ismar Lima Cavalcanti, Estêvão Luiz Carvalho Braga, Nubia Verçosa, Alberto Schanaider, Louis Barrucand, Hans Donald de Boer, Luiz Vane   +6 more
doaj   +3 more sources

A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis

Anesthesiology, 2023
Background: The dose of sugammadex recommended by the manufacturer for reversal of rocuronium is 2 mg/kg when the train-of-four count is 2 or more and 4 mg/kg when it is less than 2 but there is a posttetanic count of at least 1. The purpose of this dose-
T. Bowdle, Kishanee Haththotuwegama, S. Jelacic, Sharon T. Nguyen, K. Togashi, K. Michaelsen   +5 more
semanticscholar   +1 more source

Possible immunoglobulin-E-dependent sugammadex-induced anaphylaxis caused by an epitope other than γ-cyclodextrin: a case report

Journal of Medical Case Reports, 2021
Background Sugammadex is a synthetic γ-cyclodextrin derivative designed to selectively bind to steroidal neuromuscular blocking agents and reverse their effects.
Tatsuo Horiuchi, Tomonori Takazawa, Shinya Sakamoto, Masaki Orihara, Akihiko Yokohama, Mutsumi Uchiyama, Shigeru Saito   +6 more
doaj   +1 more source

Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials

Journal of International Medical Research, 2022
Objective To conduct a meta-analysis to compare different dosing scalars of sugammadex in a morbidly obese population for reversal of neuromuscular blockade (NMB).
Jian-Qiang Liao, Darrell Shih, Tzu-Yu Lin, Meng Lee, Cheng-Wei Lu   +4 more
doaj   +1 more source

Biological evaluation of the effect of sugammadex on hemostasis and bleeding [PDF]

Korean Journal of Anesthesiology, 2015
BackgroundNotification of sugammadex has been supplemented with a section on hemostasis, including a longer clotting time in the first minutes following injection, without any documented clinical consequences.
Julien Raft, Philippe Guerci, Valentin Harter, Thomas Fuchs-Buder, Claude Meistelman   +4 more
doaj   +1 more source

Use of sugammadex is associated with reduced incidence and severity of postoperative nausea and vomiting in adult patients with obesity undergoing laparoscopic bariatric surgery: a post-hoc analysis

BMC Anesthesiology, 2023
Background Postoperative nausea and vomiting (PONV) is a common but troublesome complication in patients who undergo laparoscopic bariatric surgery (LBS).
Xiahao Ding, Xiaozhong Zhu, Cuimei Zhao, Dapeng Chen, Yuting Wang, H. Liang, B. Gui   +6 more
semanticscholar   +1 more source

Evaluation of the vasorelaxant effect of Sugammadex on the arterial smooth muscle in rats

Medicine Science, 2023
Although NMBAs (Neuro Muscular Blocking Agents) have been used for a long time, postoperative residual curarization is still a significant problem. Nowadays, an agent named Sugammadex is used for the reversal of curarization.
Mustafa Karademir, Gulsah Altun, Dilay Karademir   +2 more
doaj   +1 more source

Sugammadex: An Update [PDF]

The Journal of Critical Care Medicine, 2016
Abstract The purpose of this update is to provide recent knowledge and debates regarding the use of sugammadex in the fields of anesthesia and critical care. The review is not intended to provide a comprehensive description of sugammadex and its clinical use.
Marwan Armaly, Alexander Sherman, Mona Boaz, Yitzhak Berlovitz, Tiberiu Ezri   +4 more
openaire   +3 more sources